Literature DB >> 15105135

Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.

Kasturi Mukhopadhyay1, Tulika Prasad, Preeti Saini, Thomas J Pucadyil, Amitabha Chattopadhyay, Rajendra Prasad.   

Abstract

In this study, we examined the importance of membrane ergosterol and sphingolipids in the drug susceptibilities of Candida albicans. We used three independent methods to test the drug susceptibilities of erg mutant cells, which were defective in ergosterol biosynthesis. While spot and filter disk assays revealed that erg2 and erg16 mutant cells of C. albicans became hypersensitive to almost all of the drugs tested (i.e., 4-nitroquinoline oxide, terbinafine, o-phenanthroline, itraconazole, and ketoconazole), determination of the MIC at which 80% of the cells were inhibited revealed more than fourfold increase in susceptibility to ketoconazole and terbinafine. Treatment of wild-type C. albicans cells with fumonisin B1 resulted in 45% inhibition of sphingolipid biosynthesis and caused cells to become hypersensitive to the above drugs. Although erg mutants displayed enhanced membrane fluidity and passive diffusion, these changes alone were not sufficient to elicit the observed hypersusceptibility phenotype of erg mutants. For example, the induction in vitro of a 12% change in the membrane fluidity of C. albicans cells by a membrane fluidizer, benzyl alcohol, did not affect the drug susceptibilities of Candida cells. Additionally, the surface localization of green fluorescent protein-tagged Cdr1p, a major drug efflux pump protein of C. albicans, revealed that any disruption in ergosterol and sphingolipid interactions also interfered with its proper surface localization and functioning. A 50% reduction in the efflux of the Cdr1p substrate, rhodamine 6G, in erg mutant cells or in cells with a reduced sphingolipid content suggested a strong correlation between these membrane lipid components and this major efflux pump protein. Taken together, the results of our study demonstrate for the first time that there is an interaction between membrane ergosterol and sphingolipids, that a reduction in the content of either of these two components results in a disruption of this interaction, and that this disruption has deleterious effects on the drug susceptibilities of C. albicans cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105135      PMCID: PMC400589          DOI: 10.1128/AAC.48.5.1778-1787.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.

Authors:  S Maesaki; P Marichal; H Vanden Bossche; D Sanglard; S Kohno
Journal:  J Antimicrob Chemother       Date:  1999-07       Impact factor: 5.790

Review 2.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

3.  Molecular aspects of fluconazole resistance development in Candida albicans.

Authors:  R Franz; M Ruhnke; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

4.  Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.

Authors:  T C White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Khafrefungin, a novel inhibitor of sphingolipid synthesis.

Authors:  S M Mandala; R A Thornton; M Rosenbach; J Milligan; M Garcia-Calvo; H G Bull; M B Kurtz
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

6.  Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance.

Authors:  G D Albertson; M Niimi; R D Cannon; H F Jenkinson
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 7.  Major facilitator superfamily.

Authors:  S S Pao; I T Paulsen; M H Saier
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

8.  Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3.

Authors:  L S Kean; A M Grant; C Angeletti; Y Mahé; K Kuchler; R S Fuller; J W Nichols
Journal:  J Cell Biol       Date:  1997-07-28       Impact factor: 10.539

Review 9.  Sphingolipids with inositolphosphate-containing head groups.

Authors:  R L Lester; R C Dickson
Journal:  Adv Lipid Res       Date:  1993

Review 10.  Physiological implications of sterol biosynthesis in yeast.

Authors:  L W Parks; W M Casey
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

View more
  48 in total

1.  In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.

Authors:  Sanjiveeni Dhamgaye; Frederic Devaux; Raman Manoharlal; Patrick Vandeputte; Abdul Haseeb Shah; Ashutosh Singh; Corinne Blugeon; Dominique Sanglard; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H+ transport.

Authors:  Ritu Pasrija; Dibyendu Banerjee; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2007-01-05

3.  Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.

Authors:  Tulika Prasad; Preeti Saini; Naseem Akhtar Gaur; Ram A Vishwakarma; Luqman Ahmad Khan; Qazi M Rizwanul Haq; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Candida albicans transcription factor Ace2 regulates metabolism and is required for filamentation in hypoxic conditions.

Authors:  Siobhan M Mulhern; Mary E Logue; Geraldine Butler
Journal:  Eukaryot Cell       Date:  2006-09-22

5.  Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance.

Authors:  Sushma Sharma; Md Alfatah; Vinay K Bari; Yashpal Rawal; Sanjoy Paul; K Ganesan
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

6.  Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks.

Authors:  Dibyendu Banerjee; Gaelle Lelandais; Sudhanshu Shukla; Gauranga Mukhopadhyay; Claude Jacq; Frederic Devaux; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2007-11-09

7.  Antagonistic changes in sensitivity to antifungal drugs by mutations of an important ABC transporter gene in a fungal pathogen.

Authors:  Wenjun Guan; Huifeng Jiang; Xiaoxian Guo; Eugenio Mancera; Lin Xu; Yudong Li; Lars Steinmetz; Yongquan Li; Zhenglong Gu
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

8.  Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p.

Authors:  Célia Ferreira; Sónia Silva; Fábio Faria-Oliveira; Eva Pinho; Mariana Henriques; Cândida Lucas
Journal:  BMC Microbiol       Date:  2010-09-15       Impact factor: 3.605

9.  Lipidomics and in vitro azole resistance in Candida albicans.

Authors:  Ashutosh Singh; Kaushal Kumar Mahto; Rajendra Prasad
Journal:  OMICS       Date:  2013-02

Review 10.  Sphingolipids and membrane biology as determined from genetic models.

Authors:  Raghavendra Pralhada Rao; Jairaj K Acharya
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-10-13       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.